LINACS
LINACS Home
OligoCare
Group

mTOR

The data below refer to patients treated with mTOR as the sole drug class, excluding any concurrent use of drugs from other groups. Combination therapy data are available in the section below.
Location
Individual Drugs

Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.

Everolimus
Nab-Sirolimus
No data
Temsirolimus
No data